SEVERANCE AGREEMENT AND GENERAL RELEASESeverance Agreement • August 8th, 2014 • Cellular Biomedicine Group, Inc. • Finance services • New York
Contract Type FiledAugust 8th, 2014 Company Industry JurisdictionThis SEVERANCE AGREEMENT AND GENERAL RELEASE (this “Agreement”) is made among (i) Keith Wong (“Employee”), an Arizona resident, (ii) CELLULAR BIOMEDICINE GROUP, INC., a Delaware corporation (the “Parent”), and (iii) EASTBRIDGE INVESTMENT CORP., a Delaware corporation wholly owned by the Parent (the “Company”). Employee, Parent and the Company are referred to collectively as the “Parties” and individually as a “Party.”
SEVERANCE AGREEMENT AND GENERAL RELEASESeverance Agreement • August 8th, 2014 • Cellular Biomedicine Group, Inc. • Finance services • New York
Contract Type FiledAugust 8th, 2014 Company Industry JurisdictionThis SEVERANCE AGREEMENT AND GENERAL RELEASE (this “Agreement”) is made among (i) Norman Klein (“Employee”), an Arizona resident, (ii) CELLULAR BIOMEDICINE GROUP, INC., a Delaware corporation (the “Parent”), and (iii) EASTBRIDGE INVESTMENT CORP., a Delaware corporation wholly owned by the Parent (the “Company”). Employee, Parent and the Company are referred to collectively as the “Parties” and individually as a “Party.”